Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic complement activation in psoriasis vulgaris

C J Fleming1, E R Holme, R M Mackie

  • 1University Department of Dermatology, Western Infirmary, Glasgow, Scotland, UK.

Clinical and Experimental Dermatology
|November 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dermatoscopic features of extrafacial lentigo maligna.

Clinical and experimental dermatology·2013
Same author

Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.

Journal of the National Cancer Institute·2010
Same author

Current trends and controversies in cutaneous melanoma.

Scottish medical journal·2010
Same author

Vitamin D in treated melanoma patients on follow up.

The British journal of dermatology·2009
Same author

Recurrent pigmented eccrine porocarcinoma presenting as carcinoma erysipeloides.

Clinical and experimental dermatology·2009
Same author

Epidemiology of invasive cutaneous melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2009
Same journal

Real-World Outcomes of Stapokibart-Based Combination Therapy for Bullous Pemphigoid: A Single-Center Retrospective Cohort.

Clinical and experimental dermatology·2026
Same journal

A second case of recessive mosaicism in ABCA12 causing a congenital unilateral epidermal nevus.

Clinical and experimental dermatology·2026
Same journal

Dermatopathology.

Clinical and experimental dermatology·2026
Same journal

Persistent Bilateral Palmar Hyperkeratotic Papules in an Adolescent Male.

Clinical and experimental dermatology·2026
Same journal

Shuddering Attacks in an Infant Treated with Atenolol for Infantile Hemangioma: A Previously Unreported Adverse Effect.

Clinical and experimental dermatology·2026
Same journal

Male genital fixed drug eruption: a systematic review.

Clinical and experimental dermatology·2026
See all related articles

Complement activation is a key feature in psoriasis vulgaris. This study found elevated serum C5b-9 complexes in patients, confirming complement system involvement in the disease.

Area of Science:

  • Immunology
  • Dermatology
  • Complement System Biology

Background:

  • Psoriasis vulgaris is a chronic inflammatory skin condition.
  • The role of the complement system in psoriasis pathogenesis is not fully understood.
  • Systemic complement activation has been suggested but not definitively proven.

Purpose of the Study:

  • To investigate evidence of systemic complement activation in patients with psoriasis vulgaris.
  • To determine if complement activation correlates with disease activity.
  • To provide a detailed analysis of complement system involvement in psoriasis.

Main Methods:

  • Studied nineteen patients diagnosed with psoriasis vulgaris.
  • Excluded patients with other known causes of systemic complement activation.

Related Experiment Videos

  • Measured serum levels of complement activation products, specifically C5b-9 complexes.

    • Main Results:

    • Nineteen patients with psoriasis vulgaris were analyzed.
    • A marked elevation in serum C5b-9 complexes was observed in all patients.
    • No other significant complement abnormalities were detected.
    • No correlation was found between C5b-9 levels and disease activity.

    Conclusions:

    • Complement activation is a confirmed feature of psoriasis vulgaris.
    • Elevated serum C5b-9 complexes indicate terminal complement pathway activation in psoriasis.
    • Further research is warranted to explore the precise mechanisms and therapeutic implications of complement activation in psoriasis.